These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 25118650)

  • 21. Cardiolipin remodeling: a regulatory hub for modulating cardiolipin metabolism and function.
    Ye C; Shen Z; Greenberg ML
    J Bioenerg Biomembr; 2016 Apr; 48(2):113-23. PubMed ID: 25432572
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cardiolipin remodeling by TAZ/tafazzin is selectively required for the initiation of mitophagy.
    Hsu P; Liu X; Zhang J; Wang HG; Ye JM; Shi Y
    Autophagy; 2015 Apr; 11(4):643-52. PubMed ID: 25919711
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Structural and functional analyses of Barth syndrome-causing mutations and alternative splicing in the tafazzin acyltransferase domain.
    Hijikata A; Yura K; Ohara O; Go M
    Meta Gene; 2015 Jun; 4():92-106. PubMed ID: 25941633
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cardiolipin metabolism and its causal role in the etiology of the inherited cardiomyopathy Barth syndrome.
    Gaspard GJ; McMaster CR
    Chem Phys Lipids; 2015 Dec; 193():1-10. PubMed ID: 26415690
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tafazzin splice variants and mutations in Barth syndrome.
    Kirwin SM; Manolakos A; Barnett SS; Gonzalez IL
    Mol Genet Metab; 2014 Jan; 111(1):26-32. PubMed ID: 24342716
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Barth syndrome cells display widespread remodeling of mitochondrial complexes without affecting metabolic flux distribution.
    Chatzispyrou IA; Guerrero-Castillo S; Held NM; Ruiter JPN; Denis SW; IJlst L; Wanders RJ; van Weeghel M; Ferdinandusse S; Vaz FM; Brandt U; Houtkooper RH
    Biochim Biophys Acta Mol Basis Dis; 2018 Nov; 1864(11):3650-3658. PubMed ID: 30251684
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Decreased pyruvate dehydrogenase activity in Tafazzin-deficient cells is caused by dysregulation of pyruvate dehydrogenase phosphatase 1 (PDP1).
    Liang Z; Ralph-Epps T; Schmidtke MW; Kumar V; Greenberg ML
    J Biol Chem; 2024 Mar; 300(3):105697. PubMed ID: 38301889
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tafazzin deficiency attenuates anti-cluster of differentiation 40 and interleukin-4 activation of mouse B lymphocytes.
    Zegallai HM; Abu-El-Rub E; Mejia EM; Sparagna GC; Cole LK; Marshall AJ; Hatch GM
    Cell Tissue Res; 2022 Dec; 390(3):429-439. PubMed ID: 36129532
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Generation of a homozygous TAZ knockout hESCs line by CRISPR/Cas9 system.
    Zhou M; Huang P; Bai R; Liu X
    Stem Cell Res; 2022 Oct; 64():102923. PubMed ID: 36219982
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cardiolipin deficiency in Barth syndrome is not associated with increased superoxide/H
    Goncalves RLS; Schlame M; Bartelt A; Brand MD; Hotamışlıgil GS
    FEBS Lett; 2021 Feb; 595(3):415-432. PubMed ID: 33112430
    [TBL] [Abstract][Full Text] [Related]  

  • 31. New C-Terminal Conserved Regions of Tafazzin, a Catalyst of Cardiolipin Remodeling.
    Shilovsky GA; Zverkov OA; Seliverstov AV; Ashapkin VV; Putyatina TS; Rubanov LI; Lyubetsky VA
    Oxid Med Cell Longev; 2019; 2019():2901057. PubMed ID: 31781330
    [TBL] [Abstract][Full Text] [Related]  

  • 32. When silence is noise: infantile-onset Barth syndrome caused by a synonymous substitution affecting TAZ gene transcription.
    Ferri L; Dionisi-Vici C; Taurisano R; Vaz FM; Guerrini R; Morrone A
    Clin Genet; 2016 Nov; 90(5):461-465. PubMed ID: 26853223
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Defining functional classes of Barth syndrome mutation in humans.
    Lu YW; Galbraith L; Herndon JD; Lu YL; Pras-Raves M; Vervaart M; Van Kampen A; Luyf A; Koehler CM; McCaffery JM; Gottlieb E; Vaz FM; Claypool SM
    Hum Mol Genet; 2016 May; 25(9):1754-70. PubMed ID: 26908608
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cardiac metabolic pathways affected in the mouse model of barth syndrome.
    Huang Y; Powers C; Madala SK; Greis KD; Haffey WD; Towbin JA; Purevjav E; Javadov S; Strauss AW; Khuchua Z
    PLoS One; 2015; 10(6):e0128561. PubMed ID: 26030409
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A case of infantile Barth syndrome with severe heart failure: Importance of splicing variants in the TAZ gene.
    Takeda A; Ueki M; Abe J; Maeta K; Horiguchi T; Yamazawa H; Izumi G; Chida-Nagai A; Sasaki D; Tsujioka T; Sato I; Shiraishi M; Matsuo M
    Mol Genet Genomic Med; 2023 Jul; 11(7):e2190. PubMed ID: 37186429
    [TBL] [Abstract][Full Text] [Related]  

  • 36. SS-31 treatment ameliorates cardiac mitochondrial morphology and defective mitophagy in a murine model of Barth syndrome.
    Russo S; De Rasmo D; Rossi R; Signorile A; Lobasso S
    Sci Rep; 2024 Jun; 14(1):13655. PubMed ID: 38871974
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A new murine model of Barth syndrome neutropenia links TAFAZZIN deficiency to increased ER stress-induced apoptosis.
    Sohn J; Milosevic J; Brouse T; Aziz N; Elkhoury J; Wang S; Hauschild A; van Gastel N; Cetinbas M; Tufa SF; Keene DR; Sadreyev RI; Pu WT; Sykes DB
    Blood Adv; 2022 Apr; 6(8):2557-2577. PubMed ID: 34979560
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genetic modifiers modulate phenotypic expression of tafazzin deficiency in a mouse model of Barth syndrome.
    Wang S; Yazawa E; Keating EM; Mazumdar N; Hauschild A; Ma Q; Wu H; Xu Y; Shi X; Strathdee D; Gerszten RE; Schlame M; Pu WT
    Hum Mol Genet; 2023 Jun; 32(12):2055-2067. PubMed ID: 36917259
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cardiac mitochondrial structure and function in tafazzin-knockdown mice.
    Kim J; Lee K; Fujioka H; Tandler B; Hoppel CL
    Mitochondrion; 2018 Nov; 43():53-62. PubMed ID: 30389594
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cardiolipin metabolism regulates expression of muscle transcription factor MyoD1 and muscle development.
    Vo L; Schmidtke MW; Da Rosa-Junior NT; Ren M; Schlame M; Greenberg ML
    J Biol Chem; 2023 Mar; 299(3):102978. PubMed ID: 36739949
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.